Sparsentan for treating primary IgA nephropathy

  • Technology appraisal guidance
  • TA1074
  • Published: 
  • Last updated: 
Download guidance (PDF)

6 Update information

October 2025: We updated recommendations 1.1 and 1.2 to change the unit for urine protein-to-creatinine ratio (UPCR) to mg/mmol from g/g. A UPCR of 85 mg/mmol or more equates to the 0.75 g/g or more measurement specified in the marketing authorisation indication for sparsentan. A UPCR of 199 mg/mmol or more equates to 1.76 g/g or more.

ISBN: 978-1-4731-7243-2